Silicon Hills Wealth Management’s AbbVie ABBV Stock Holding History

Silicon Hills Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$662K	Buy	4,912 +321	+7%	+$47.1K	0.37%	43
2023 Q1	$732K	Hold	4,591	–	–	0.44%	41
2022 Q4	$742K	Sell	4,591 -75	-2%	-$11.5K	0.55%	43
2022 Q3	$626K	Buy	4,666 +74	+2%	+$10.6K	0.5%	44
2022 Q2	$703K	Sell	4,592 -21	-0.5%	-$3.21K	0.51%	45
2022 Q1	$748K	Sell	4,613 -21	-0.5%	-$3.05K	0.48%	51
2021 Q4	$627K	Sell	4,634 -100	-2%	-$11.8K	0.39%	62
2021 Q3	$511K	Buy	4,734 +64	+1%	+$7.31K	0.35%	67
2021 Q2	$526K	Hold	4,670	–	–	0.41%	59
2021 Q1	$505K	Hold	4,670	–	–	0.46%	59
2020 Q4	$500K	Sell	4,670 -100	-2%	-$9.61K	0.45%	52
2020 Q3	$418K	Buy	4,770 +100	+2%	+$9.41K	0.43%	57
2020 Q2	$459K	Hold	4,670	–	–	0.55%	50
2020 Q1	$356K	Buy	4,670 +4,664	+77,733%	+$397K	0.47%	57
2019 Q4	$427	Buy	+6	New	+$498	0.33%	60

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Silicon Hills Wealth Management's ABBV Position: Q2 2023 in Review

Silicon Hills Wealth Management increased its AbbVie (ABBV) stake by 7% in Q2 2023, buying an estimated $47.1K and bringing the position to 4,912 shares worth $662K. The position accounts for 0.37% of the portfolio, ranked #43.

Silicon Hills Wealth Management first reported a position in ABBV in Q4 2019 and has held it in 15 quarters since. The position peaked at $748K in Q1 2022. 3,077 funds tracked by Wall St. Rank hold ABBV as of Q2 2023.

Silicon Hills Wealth Management held 4,912 shares of AbbVie worth $662K as of Q2 2023.
Silicon Hills Wealth Management bought 321 AbbVie shares in Q2 2023, an estimated $47.1K.
AbbVie made up 0.37% of Silicon Hills Wealth Management's portfolio in Q2 2023, its #43 holding.
Silicon Hills Wealth Management first reported a position in AbbVie in Q4 2019 and has held it in 15 quarters since.
Silicon Hills Wealth Management's AbbVie position peaked at $748K in Q1 2022.
3,077 funds tracked by Wall St. Rank held AbbVie as of Q2 2023.

Based on Silicon Hills Wealth Management's 13F filing for Q2 2023, filed 14 Aug 2023.